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Abstract		Bovine	 pancreatic	 trypsin	 inhibitor	 (BPTI)	 is	 a	 well-studied	 model	 for	 investigation	 of	protein	 folding	 and	 stability.	 Here	we	 report	 the	 synthesis	 and	 characterization	 of	wild-type	 BPTI	 and	 a	 diastereomeric	 protein	 analogue	 [Gly37D-Ala]BPTI.	 Each	 58-residue	polypeptide	chain	was	made	by	native	chemical	ligation	of	two	peptide	segments,	BPTI[1-29]-αthioester	and	the	appropriate	version	of	 the	 [Cys30-58]BPTI	segment.	Boc	chemistry	
in	 situ	 neutralization	 solid	 phase	 synthesis	 was	 used	 to	 prepare	 the	 peptide	 segment	reactants.	 	 The	 resulting	 full-length	polypeptide	 chains	were	 folded	 in	 a	 cysteine/cystine	redox	buffer	to	give	synthetic	protein	molecules	containing	three	disulfide	bonds.	Synthetic	proteins	were	 characterized	 by	 analytical	 LCMS	 and	 by	 natural-abundance	 1H-15N	 HSQC	NMR	fingerprinting.	These	results	illustrate	the	power	of	Boc	chemistry	peptide	synthesis	and	its	utility	for	the	total	chemical	synthesis	of	protein	molecules.		
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Introduction		Bovine	pancreatic	trypsin	inhibitor	(BPTI)	is	the	prototypical	Kunitz-type	serine	protease	inhibitor.1	 BPTI	 has	 a	 58	 amino	 acid	 residue	 polypeptide	 chain	 in	 an	 alpha/beta	 fold	constrained	by	three	disulfide	bonds.	Dynamic	features	of	the	BPTI	protein	molecule	have	been	widely	studied,	because	 it	 is	a	good	model	 for	NMR	studies	of	 tyrosine	ring	 flipping	and	 sub-global	 NH	 exchange	 in	 a	 globular	 protein.	 A	 [Gly37Ala]BPTI	 mutant	 has	 been	described	that	destabilized	the	protein	by	~5	kcal/mol.2	Although	the	average	structure	of	the	BPTI	protein	was	retained,	 the	addition	of	 just	one	side	chain	methyl	group	in	an	Ala	residue	at	position	37	of	 the	BPTI	polypeptide	chain	caused	dramatic	perturbation	 in	the	dynamics,	leading	to	a	large	decrease	in	global	stability,	and	a	significant	increase	in	local	flexibility	 of	 the	 loop	 domain.	 This	 was	 ascribed	 to	 disruption	 of	 the	 NH-aromatic-NH	network	of	interactions	(between	the	Gly37	backbone	HN,	the	Tyr35	aromatic	ring,	and	the	side	chain	HN	of	Asn44),	which	is	energetically	costly	and	may	involve	other	cooperatively	linked	interactions.2	To	further	probe	the	role	of	the	Gly37	residue	in	the	NH-aromatic-NH	network	of	interactions,	we	undertook	the	total	chemical	synthesis	of	a	BPTI	analogue	with	D-Ala	substituted	at	position	37.	The	BPTI	polypeptide	chain	backbone	phi,	psi	angles	for	Gly37	 [Φ	 +103o,	 Ψ	 -3o]	 suggest	 that	 a	 D-Ala	 residue	 could	 be	 accommodated	 at	 that	position.3	There	are	a	number	of	published	examples	in	which	total	or	semi-synthesis	of	a	protein	molecule	 has	 been	 used	 to	 substitute	 a	 D-Ala	 residue	 for	 a	 Gly	 residue	 that	 has	backbone	phi,	psi	angles	typical	of	a	D-amino	acid	residue.4-7			Total	chemical	synthesis	of	proteins	presents	unique	advantages:	it	provides	total	control	over	the	covalent	structure	of	the	protein	molecule	and	enables	introduction	of	non-coded	moieties	 such	 as	 the	D-amino	 acids.8	 Chemical	 ligation	methods,	which	 are	 based	 on	 the	chemoselective	reaction	between	two	mutually	reactive	groups	in	order	to	unambiguously	condense	unprotected	peptide	segments,9	have	dramatically	increased	the	ease	with	which	homogeneous	preparations	of	protein	molecules	can	be	made	by	total	synthesis.	The	most	effective	condensation	method,	native	chemical	ligation	(NCL),10	involves	reaction	between	a	peptide-αthioester	and	the	amino-terminal	cysteine	of	a	second	Cys-peptide	segment:	an	initial	 thioester-linked	 intermediate	 undergoes	 spontaneous	 intramolecular	
rearrangement	to	give	a	native	peptide	bond	at	the	Xaa-Cys	ligation	site.	Because	the	initial	transthioesterification	 is	 reversible	 in	 the	 presence	 of	 added	 aromatic	 thiol	 under	 the	reaction	 conditions	 used,	 internal	 Cys	 residues	 can	 be	 present	 in	 the	 reacting	 peptide	segments.8		Stepwise	 Boc	 chemistry	 solid	 phase	 peptide	 synthesis	 (SPPS)	 can	 be	 used	 to	make	 high	purity,	homogeneous	peptides	of	up	to	40	amino	acids	in	good	yield	and	defined	covalent	structure.11	In	particular,	in	situ	neutralization	Boc	chemistry	SPPS,12		which	was	originally	introduced	in	order	to	minimize	so-called	‘difficult’	sequences	in	chain	assembly,	is	ideally	suited	 to	 the	 preparation	 of	 peptide	 thioesters	 for	 chemical	 protein	 synthesis	 by	 native	chemical	 ligation.13	 Making	 peptide	 thioesters	 by	 conventional	 Boc	 chemistry	 SPPS	 is	problematic,	 because	 a	 pre-existing	 thioester	 moiety	 is	 susceptible	 to	 attack	 by	 the	neutralized	peptide	chain	during		every	neutralization	step.			In	 the	work	reported	here,	we	describe	 the	 total	synthesis	of	model	protein	BPTI	and	 its	disatereomeric	 analogue	 [Gly37D-Ala]BPTI,	 using	 peptides	 prepared	 by	 Boc	 chemistry	SPPS.	Full-length	synthetic	polypeptide	chains	were	assembled	by	native	chemical	ligation,	and	 folded	 with	 formation	 of	 three	 disulfides	 to	 give	 the	 two	 synthetic	 BPTI	 protein	molecules;	 these	 were	 characterized	 by	 analytical	 LCMS	 and	 1H-15N	 HSQC	 NMR	spectroscopy.14		
Materials	and	Methods	Boc-L-amino	 acids,	 Boc-Gly,	 Boc-D-Ala,	 S-trityl-β-mercaptopropionic	 acid,	 and	 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium	 hexafluorophosphate	 (HBTU)	 were	obtained	from	the	Peptide	Institute	Inc.	(Osaka,	Japan).	Boc-Ala-OCH2-Pam-resin	and	N,N-diisopropylethylamine	 (DIEA)	were	 obtained	 from	Applied	 Biosystems	 (Foster	 City,	 CA).	N,N-dimethylformamide	 (DMF),	 dichloromethane	 (DCM),	 triisopropylsilane	 (TIPS),	 and	acetonitrile	 were	 obtained	 from	 Fisher	 (Chicago,	 IL).	 Trifluoroacetic	 acid	 (TFA)	 was	purchased	 from	 Halocarbon	 (New	 Jersey).	 4-Mercaptophenylacetic	 acid	 (MPAA)	 and	 p-cresol	were	from	Sigma-Aldrich	(St.	Louis,	MO).			
Analytical	reversed-phase	HPLC	with	online	mass	spectrometry	(LCMS)	was	performed	on	an	 Agilent	 1100	 Series	 instrument	 equipped	 with	 an	 MSD	 ion	 trap,	 using	 a	 Vydac	 C18	column	(2.1	mm	X	150	mm).	Chromatographic	separations	were	performed	using	a	linear	gradient	 (5-65%)	 of	 buffer	 B	 in	 buffer	 A	 over	 15	minutes	 at	 a	 flow	 rate	 of	 0.5	mL/min.	Buffer	A	=	0.1%	TFA	in	water,	buffer	B	=	0.08%	TFA	in	acetonitrile.	MS	data	were	acquired	across	 the	entirety	of	 each	UV	absorbing	peak	 for	which	a	mass	 is	 reported.	The	masses	were	 derived	 from	 the	 m/z	 values	 of	 the	 different	 protonation	 states	 of	 a	 particular	molecular	species.			Peptides	 were	 made	 manually	 on	 Boc-Ala-OCH2-Pam-(copoly)styrene-1%meta	divinylbenzene	 resin	 using	 in	 situ	 neutralization	 Boc	 chemistry	 solid	 phase	 peptide	synthesis,12	 with	 HBTU	 activation.	 Side	 chain	 protection	 for	 Boc-amino	 acids	 was	 as	follows:	 Arg(Tos),	 Asn(Xan),	 Asp(OcHex),	 Cys(4-CH3-Bzl),	 Glu(OcHex),	 Lys(2-Cl-Z),	Ser(Bzl),	Tyr(Br-Z).	All	amino	acids	were	of	 the	L	configuration,	except	 for	 the	Boc-D-Ala	used	in	preparation	of	the	diastereomer.	Synthesis	of	BPTI(1-29)αthioester	was	performed	on	 a	 0.4	mmol	 scale.	 S-Trityl-β-mercaptopropionic	 acid	was	 coupled	 to	 deprotected	 and	neutralized	Ala-OCH2-Pam-Resin	for	1	hr.	The	trityl	group	was	removed	by	treatment	with	2.5%	TIPS/2.5%	H2O/95%	TFA.13	Boc-Leu	was	 coupled	 to	 the	β-mercaptopropionyl-Ala-OCH2-Pam-Resin	 for	 20	min.	During	 SPPS	 chain	 elongations,	when	 the	N-terminal	 amino	acid	was	Boc-Gln,	DCM	was	used	to	wash	before	and	after	TFA	deprotection.12	Synthesis	of	the	peptide	 (Cys30-58)BPTI	and	 the	corresponding	analogue	 (Cys30-58)	 [Gly37D-Ala]BPTI	peptide,	was	on	a	0.2	mmol	scale.	After	assembly	of	each	peptide	chain	was	complete,	the	peptide	was	deprotected	and	cleaved	from	the	resin	support	using	anhydrous	HF/p-cresol	(90:10,	v/v)	for	1	h	at	0	oC.	After	evaporation	of	the	HF	under	reduced	pressure,	the	crude	peptide	 product	 was	 precipitated	 and	 triturated	 with	 chilled	 diethyl	 ether,	 and	 then	dissolved	 in	 50%	 acetonitrile	 in	 H2O	 containing	 0.1%	TFA.	 An	 aliquot	 from	 the	 solution	containing	the	crude	peptide	product	was	analyzed	by	LCMS	before	lyophilization.			Native	chemical	ligations	were	performed	in	parallel	in	3	mL	aqueous	solution	containing	6	M	Gn.HCl,	0.2	M	Na2HPO4,	50	mM	MPAA,	20	mM	TCEP-HCl,	pH	6.7,	at	a	concentration	of	~2	mg/mL	 (~0.6	mM)	 of	 each	 reacting	 peptide.	 Progress	 of	 the	 reactions	 was	 analyzed	 by	
analytical	LCMS.	Ligations	were	essentially	complete	at	6	h,	but	for	reasons	of	convenience,	the	 reactions	 were	 allowed	 to	 continue	 overnight.	 After	 each	 native	 chemical	 ligation	reaction	 was	 complete,	 solid-phase	 extraction	 was	 performed	 to	 remove	 low	 molecular	weight	compounds	using	Alltech	C18-LP	cartridges.	The	cartridges	were	first	equilibrated	with	 10	 mL	 100%	 methanol,	 10	 mL	 50%/50%	 A/B,	 and	 10	 mL	 100%	 A.	 The	 reaction	mixtures	were	slowly	loaded	onto	the	cartridges	dropwise	and	subsequently	washed	with	5	 mL	 5%	 B	 in	 A.	 The	 crude	 peptide	 was	 eluted	 using	 50%/50%	 A/B	 and	 the	 eluate	analyzed	by	LCMS.			The	 wild-type	 BPTI	 polypeptide	 chain	 and	 the	 analogue	 [Gly37D-Ala]BPTI	 polypeptide	chain	 were	 separately	 folded,	 with	 concomitant	 formation	 of	 disulfide	 bonds,	 at	 a	polypeptide	concentration	of	~0.3	mg/mL	in	aqueous	solution	containing	2	M	Gn.HCl,	6.13	mM	L-cysteine,	0.8	mM	L-cystine,	67	mM	Tris,	pH	7.7-7.9.	During	the	folding	reactions,	no	stirring	 was	 performed.	 Progress	 of	 the	 reactions	 was	 monitored	 by	 analytical	 LCMS.	Folding	 was	 complete	 within	 6-7	 h.	 Folded	 BPTI	 and	 folded	 analogue	 [Gly37D-Ala]BPTI	were	purified	by	preparative	HPLC	performed	on	a	Vydac	C18	column	(10	mm	X	250	mm)	at	a	 flow	rate	of	5	mL/min,	with	a	gradient	of	5-25%	B	over	20	minutes,	 then	25-50%	B	over	25	minutes.	Fractions	were	pooled	based	on	LCMS	analysis.	Purified	folded	wild-type	BPTI	and	folded	[Gly37D-Ala]BPTI	proteins	were	characterized	by	analytical	LCMS.		1H-15N	 HSQC	 spectra	 of	 wild-type	 BPTI	 and	 [Gly37D-Ala]BPTI	 were	 acquired	 at	 natural	abundance	(proton	frequency	700	MHz)	in	H2O/D2O	(10%	D2O)	at	pH	4.6	and	25	oC	using	a	Bruker	 Avance	 NMR	 spectrometer	 equipped	 with	 [x,y,z]-gradient	 triple-resonance	cryoprobe.	Protein	concentrations	were	in	each	case	~1	mM.				
	
	
	
	
Results	and	Discussion		The	amino	acid	sequence	of	 the	BPTI	polypeptide	chain	 is	shown	in	Figure	1.15	The	BPTI	protein	 molecule	 contains	 three	 disulfide	 bonds,	 connecting	 residues	 Cys5-Cys55,	 Cys14-Cys38,	and	Cys30-Cys51.		
R.1PDFCLEPPY T11GPCKARIIR Y21FYNAKAGLC Q31TFVYGGCRA 
K41RNNFKSAED C51MRTCGGA58  
 
Figure	1.		Amino	acid	sequence	of	BPTI.		Synthetic	Scheme.	The	58	amino	acid	residue	polypeptide	chain	has	a	Leu29-Cys30	ligation	site	 at	 the	 exact	 center	 of	 its	 sequence,	 ideally	 placed	 for	 synthesis	 by	 native	 chemical	ligation.8	A	scheme	for	 the	convergent	synthesis	of	BPTI	 from	two	29	amino	acid	residue	peptides	is	shown	in	Figure	2.	
	
Figure	2.	Convergent	total	synthesis	of	BPTI.	Peptide	segment	reactants	were	made	by	Boc	chemistry	SPPS	and	covalently	condensed	by	native	chemical	ligation	(NCL).8	The	resulting	58	amino	acid	residue	full-length	polypeptide	chain	was	folded	with	concomitant	formation	of	disulfides	under	standard	redox	conditions.	 (Image	of	BPTI	generated	 from	PDB	code:	1BPI)	
	Peptide	 Synthesis.	 Peptide	 segments	 were	made	 by	 in	 situ	 neutralization	 Boc	 chemistry	stepwise	 SPPS.12	 For	 synthesis	 of	 the	 thioester	 segment	 BPTI(1-29)-COSR,	 where	 R=	SCH2CH2-Ala,	 the	 C-terminal	 Boc-Leu	 residue	 of	 the	 target	 sequence	 was	 coupled	 to	HSCH2CH2-Ala-OCH2Pam-Resin.	 After	 the	 peptide	 chain	 had	 been	 assembled	 in	 stepwise	fashion,	 the	 resin-bound	 peptide	 was	 simultaneously	 deprotected	 and	 cleaved	 from	 the	resin	 by	 treatment	with	HF,	 to	 give	 the	peptide	 thioester	BPTI(1-30)-COSCH2CH2-Ala-OH.	The	wild-type	BPTI	sequence	Cys-peptide	segment	Cys30-Ala58	was	synthesized	directly	on	Boc-Ala-OCH2Pam-Resin,	 and	 the	 analogue	 segment	 was	 made	 in	 the	 same	 fashion,	substituting	 D-Ala	 for	 Gly	 at	 residue	 position	 37.	 Crude	 peptides	 were	 purified	 by	preparative	HPLC,	and	characterized	by	LCMS.	Examples	of	the	synthetic	peptide	segments	are	shown	in	Figure	3.																
			
		
		
Figure	 3.	 LCMS	 characterization	 of	 purified	 peptide	 segments	 made	 by	 Boc	 chemistry	SPPS.	Panel	A.	Purified	BPTI(1-29)-thioester.	Observed	mass	3520.3	±	0.2	Da	[Calculated	mass:	 3520.0	 Da	 (average	 isotope	 composition)]	 Panel	 B.	 Purified	 (Cys30-58)BPTI.	Observed	 mass	 3174.4	 ±	 0.4	 Da	 [Calculated	 mass:	 3174.6	 Da	 (average	 isotope	composition)]	Panel	C.	Purified	(Cys30-58)	[Gly37D-Ala]BPTI.	Observed	mass	3188.4		±	0.2	Da	[Calculated	mass:	3188.6	Da	(average	isotope	composition)]	
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Chemical	 Ligation.	 To	 prepare	 the	 full-length	 synthetic	 polypeptide	 chains,	 the	 peptide-thioester	and	Cys-peptide	segments	were	condensed	by	native	chemical	ligation	in	aqueous	6	M	Gn.HCl	in	phosphate	buffer	at	pH	6.7	in	the	presence	of	50	mM	MPAA	as	an	aromatic	thiol	 catalyst.	 The	 NCL	 reactions	 were	 essentially	 complete	 after	 six	 hours,	 but	 for	convenience	were	allowed	to	proceed	for	24	hours.	Data	for	synthesis	of	the	wild-type	BPTI	and	[Gly37D-Ala]BPTI	polypeptide	chains	are	shown	in	Figures	4	&	5,	respectively.	
	
			
Figure	 4.	 Synthesis	 of	 the	 wild-type	 BPTI(1-58)	 polypeptide	 chain.	 Panels	 A	 &	 B:	Analytical	 LCMS	 monitoring	 of	 the	 NCL	 reaction	 at	 T=0;	 t=	 24h,	 respectively.	 Observed	mass	 of	 the	 ligation	 product:	 6516.0	 ±	 0.5	 Da	 [Calculated	 masses:	 6513.1	 Da	(monoisotopic);	6517.5	Da	(average	 isotope	composition)]	MS	data	were	acquired	across	the	entirety	of	each	UV	absorbing	peak	for	which	a	mass	is	reported.		
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Figure	 5.	 	 Synthesis	 of	 the	 [Gly37D-Ala]BPTI(1-58)	 polypeptide	 chain.	 Panels	 A	 &	 B:	Analytical	LCMS	monitoring	of	the	NCL	reaction	at	T=0;	t=	24h,	respectively.	The	full-length	polypeptide	chain	[Gly37D-Ala]BPTI(1-58)	had	observed	mass:	6530.0	±	0.5Da	[Calculated	masses:	6527.1	Da	(monoisotopic);	6531.5	Da	(average	isotope	composition)]			Folding.	 Synthetic	 protein	 molecules	 were	 obtained	 by	 separately	 folding	 the	 two	 full-length	 polypeptide	 chains,	 with	 concomitant	 formation	 of	 disulfides,	 in	 a	 redox	 buffer	containing	 a	moderate	 concentration	 of	 guanidine.HCl	 as	 a	 solubilizing	 agent	 in	 order	 to	keep	 misfolded	 forms	 of	 the	 polypeptide	 chains	 in	 solution,	 according	 to	 the	 principles	developed	by	Rudolph	and	coworkers	for	refolding	proteins	expressed	as	inclusion	bodies	in	recDNA-engineered	E.	coli.16	Here	we	used	a	redox	buffer	consisting	of	6.13	mM	cysteine	and	 0.8	 mM	 cystine	 in	 67	 mM	 Tris	 at	 pH	 7.8,	 with	 2	 M	 Gn.HCl.	 The	 synthetic	 protein	molecules	were	purified	by	reversed	phase	HPLC.				
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Characterization.	 The	 purified	 synthetic	 proteins	were	 characterized	 by	 analytical	 LCMS.	Data	for	the	folded	wild-type	BPTI	synthetic	protein	is	shown	in	Figure	6.		
	
	
Figure	 6.	 Analytical	 LCMS	 of	 purified	 wild-type	 BPTI	 synthetic	 protein.	 The	 folded	synthetic	 protein	 had	 observed	 mass	 6510.0	 ±	 0.5	 Da	 [Calculated	 masses:	 6507.1	 Da	(monoisotopic);	6511.5	Da	(average	isotope	composition)]		The	 observed	mass	 of	 the	 folded	wild-type	BPTI	 protein	was	6510.0	 ±	 0.5	Da	 compared	with	6516.0	±	0.5	Da	for	the	linear	polypeptide	chain,	a	mass	difference	of	6	Da,	consistent	with	 the	 formation	 of	 three	 disulfide	 bonds	 in	 the	 folded	 protein	 molecule.	 A	 similar	reduction	in	mass	of	6.5	Da	was	observed,	from	6530.0	±	0.5	Da	for	the	linear	polypeptide	chain	to	6523.5	±	0.5	Da,	for	the	folded	[Gly37D-Ala]BPTI	analogue	protein,	which	was	thus	also	shown	to	contain	three	disulfides.		
	Synthetic	 wild-type	 BPTI	 and	 [Gly37D-Ala]BPTI	 proteins	 were	 characterized	 	 by	 1H-15N	natural-abundance	 HSQC	 NMR	 ‘fingerprinting’	 (Figure	 7).13’	 Both	 proteins	 exhibited	marked	 dispersion	 of	 2D	 NMR	 cross-peaks	 as	 is	 characteristic	 of	 well-folded	 protein	molecules	 that	 have	 a	 single,	 well-defined	 tertiary	 structure.	 The	 synthetic	 proteins	exhibited	 similar	 NMR	 fingerprint	 spectra,	 with	 only	 ~7	 residues	 showing	 significantly	perturbed	chemical	shifts.	
		
Figure	7.	1H-15N	HSQC	fingerprints	of	wild-type	BPTI	and	[Gly37D-Ala]BPTI.	(A)	Overlay	of	1H-15N	 HSQC	 spectra	 of	 wild-type	 BPTI	 (Gly37;	 black	 cross-peaks)	 and	 the	 [Gly37D-Ala]BPTI	 analogue	 (red	 cross-peaks).	 (B)	 Ribbon	 presentation	 of	 BPTI	 crystal	 structure	(PDB	entry	1K6U).	The	green	sphere	 indicates	position	of	the	Gly37	main-chain	nitrogen,	and	 magenta	 spheres	 indicate	 main-chain	 nitrogen	 atoms	 of	 residues	 that	 exhibit	perturbed	 chemical	 shifts	 in	 the	 [Gly37D-Ala]BPTI	 analogue's	 HSQC	 spectrum.	 Disulfide	bridges	are	highlighted	in	gold,	with	smaller	spheres	indicating	the	sulfur	atoms.		
	
	
	
	
	
	
	
Conclusions		
Wild-type	 BPTI	 and	 a	 diastereomeric	 analogue	 BPTI	 protein	 substituted	 with	 D-Ala	 at	position	 37	 were	 synthesized	 by	 Boc	 chemistry	 SPPS	 combined	 with	 native	 chemical	ligation.	 The	 D-Ala	 substituted	 BPTI	 variant	 [G37D-Ala]BPTI	 should	 provide	 additional	insights	 into	 the	 effect	 of	 restrictions	 of	main	 chain	 dihedral	 angles	 on	 local	 and	 larger-distance	conformational	fluctuations	in	the	BPTI	protein	molecule.2	Studies	of	the	effects	of	the	 ‘D-Gly37’→D-Ala37	 substitution	 on	 folding	 efficiency,	 thermodynamic	 stability	 and	dynamic	 features	 will	 be	 reported	 separately.	 Of	 particular	 interest	 will	 be	 potential	stereospecific	 damping	 of	 Tyr35	 side-chain	 ‘flipping’	 and	 subglobal	 native-state	 amide	proton	exchange	in	D2O	solution	relative	to	the	markedly	enhanced	flexibility	described	in	the	L-Ala37	analogue.2		The	utility	of	Boc	chemistry	SPPS	is	vividly	illustrated	by	the	work	reported	here.	In	1957	Carpino	 introduced	 the	 acid	 labile	 tert-butyloxycarbonyl	 (Boc)	 group	 for	 amine	protection.17	 It	was	 swiftly	 adopted	 for	 use	 in	 peptide	 chemistry,18	 and	NαBoc-protected	amino	acid	chemistry	dominated	 the	burgeoning	 field	of	peptide	synthesis	 for	more	 than	four	decades,	and	is	still	used	in	the	present	day.	In	1972	Carpino	introduced	the	base	labile	fluorenylmethyloxycaronyl	 (Fmoc)	 group	 for	 amine	 protection.19	 Embodied	 in	 Fmoc	chemistry	SPPS,20	it	is	now	almost	universally	used	for	the	chemical	synthesis	of	peptides	and,	 in	combination	with	modern	chemical	 ligation	methods,	 is	becoming	widely	used	for	the	total	chemical	synthesis	of	protein	molecules.21-23		---------------------------------		
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